Aprea Therapeutics, Inc.·4

Aug 1, 5:05 PM ET

Peters Richard 4

4 · Aprea Therapeutics, Inc. · Filed Aug 1, 2022

Insider Transaction Report

Form 4
Period: 2022-07-28
Transactions
  • Award

    Common Stock

    2022-07-28+5,99510,605 total
  • Award

    Stock Option (right to Buy)

    2022-07-28+29,57529,575 total
    Exercise: $1.09Exp: 2032-07-28Common Stock (29,575 underlying)
Footnotes (2)
  • [F1]These shares represent restricted stock units which were granted on July 28, 2022, and which will vest and be settled in common stock on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
  • [F2]The option vests in full on July 28, 2023, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.

Documents

1 file
  • 4
    tm2222147-8_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT